Viral oncolysates of Newcastle disease virus (NDV) have been widely used for the treatment of malignant melanoma. Apparently, this nononcogenic and apathogenic paramyxovirus can alter the immunogenicity of tumor cells. To determine the influence of NDV infection on a tumor-specific T-cell response on a functional level, we used autologous primary melanoma cells infected with the NDV-strain Ulster. Therefore, melanoma cells and tumor-infiltrating lymphocytes were prepared from a freshly resected tumor, and tumor-infiltrating lymphocytes were subjected to limited dilution cloning. Proliferation assays of the T-helper cell clone sTS3 (CD4 ϩ )
A pproaches to induce tumor regression by injection of attenuated virus or viral proteins have been under investigation since the early 1960s. [1] [2] [3] Active immunization with Newcastle disease virus (NDV), an avian paramyxovirus with no severe side effects upon systemic application, was shown to be an effective approach for the treatment of malignant melanoma, as well as other tumors (i.e., renal cell carcinoma, neuroblastoma, and fibrosarcoma). 4 -9 The attenuated strain 73-T of NDV possesses oncolytic activity against melanoma cells and has been successfully applied in several clinical trials as a tumor vaccine. 6, 7 In addition, individual live-cell vaccines of the apathogenic, nonlytic NDV strain Ulster have been shown to be of benefit for postoperative active specific immunotherapy of cancer patients. 10 -13 Recently, oncolysate vaccines administered in a phase III, multi-institutional melanoma trial showed a significant survival benefit for a subset of patients; 5 other trials demonstrated a prolonged diseasefree survival in up to 60% of patients with melanoma. 2, 6, 7 The NDV vaccination protocols of these trials consisted of cell membranes of in vitro NDV-infected tumor cells; 2, 6, 7 other trials used attenuated live virus as a vaccine component, 4 and in a third group virus-infected live cell vaccine was used. 10 -13 The mechanisms by which the virus enhances the tumor immunogenicity are only partially resolved. NDV possesses a direct cytotoxic antitumoral activity; 14, 15 furthermore, it was found to induce cytokine production by macrophages. 4 But more importantly, it can also function as a potent costimulator for specific immune responses against a variety of cancers, 16 -19 because NDV infection has been shown to up-regulate the expression of adhesion molecules 19 and to induce interferon-␣ production. 17 The in vivo immunity against malignant melanoma is mainly dependent upon the development of a specific T-cell response mediated by cytotoxic major histocompatibility complex (MHC) class I antigen (Ag)-restricted CD8 ϩ T cells and MHC class II-restricted CD4 ϩ Thelper (Th) cells. 20, 21 However, tumor cells can escape from this Ag-specific T-cell response by the induction of unresponsiveness in T lymphocytes (reviewed in Ref. 22) . This state of anergy in T cells is characterized by the inability to produce interleukin-2 (IL-2) and to prolifer-ate; it is induced by T-cell receptor (TCR) stimulation in the absence of a second costimulatory signal mediated by the CD28 receptor on the T cells (reviewed in Ref. 22) . Stimulatory signals mediated by cross-linking of both the TCR and CD28 lead to activation of the IL-2 promoter and subsequently to gene transcription and IL-2 production. 23, 24 CD28-dependent intracellular signaling pathways finally lead to formation of the CD28-responsive complex, which is composed of members of the nuclear factor-B-Rel-family and binds to the CD28-responsive element (CD28RE) on the IL-2 promotor. 25, 26 Ligands of the CD28 receptor and the main transmitters of costimulation are the members of the B7 family; two of them, B7-1 and B7-2, are well characterized, 22, 27 but the existence of other costimulatory factors has been postulated. 28 Melanoma cells were found to synthesize or express only low levels of B7 molecules. 29, 30 However, the expression of these molecules is not functional, because we and others have demonstrated that tumorinfiltrating lymphocytes (TILs) isolated from freshly resected melanomas are largely anergic against their parent tumor. 31, 32 Other molecules expressed on melanoma cells with costimulatory activity (i.e., CD40 33, 34 or intercellular adhesion molecule -1 35 ) cannot prevent the induction of anergy in T cells.
Therefore, elucidation of the molecular mechanisms that prevent the induction of T-cell clonal anergy might help to develop more effective vaccination strategies for the treatment of malignant melanoma. We have addressed the NDV-mediated inhibition of tumor growth in an autologous human melanoma model. In this specific system, NDV infection of melanoma cells induced the activation of Th cells and the prevention of clonal anergy, mediated by a costimulatory factor different from B7-1/B7-2.
MATERIALS AND METHODS

Antibodies (Abs)
The following monoclonal Abs (mAbs) were used for phenotyping of the T-cell clone sTS3, detection of costimulatory molecules on melanoma cells, and T-cell proliferation assays: anti-CD2 (clone XIX0.8), anti-CD3 (clone UCHT-1), anti-CD4 (clone MEM115), anti-CD11a (clone 38), anti-CD14 (clone UCHM-1), anti-CD16 (clone CB16), anti-CD21 (clone BU33), anti-CD25 (clone TU69), anti-CD56 (clone MEM 188), anti-B7-1 (CD80) (clone BB-1), anti-B7-2 (CD86) (clone BU63), immunoglobulin G-isotype control, and a secondary fluorescein isothiocyanate-labeled goat anti-mouse F(abЈ) 2 -immunoglobulin G (no. 115-095-006); all were purchased from Dianova (Hamburg, Germany). Anti-human histocompatibility leukocyte Ag (HLA)-ABC (clone W6/32), ␤ 2 -microglobulin (clone DK22), anti-CD28 (clone 28.5), and anti-HLA-DR (clone 1B5) mAbs were obtained from Dako (Hamburg, Germany).
Melanoma cell lines
Dispersed cells were obtained by grating tumor fragments from freshly resected melanomas against a 0.3 ϫ 0.3-mm metallic mesh (Sigma, Deisenhofen, Germany) immersed in c-RPMI, consisting of RPMI 1640 medium supplemented with 5% fetal calf serum, 1% penicillin, 1% streptomycin, 1% glutamine, and 1% sodium pyruvate (Seromed, Mannheim, Germany). The cell suspension was plated into 6-well collagen-coated culture plates at 2000 cells/well (37°C, 5% CO 2 ). Tumor cell lines were maintained as monolayers and passaged by limited trypsinization.
NDV infection of melanoma cells
Melanoma cell infection was performed as described previously. 10 -13 Briefly, 100 hemagglutinating units of the NDV strain Ulster were added to 50% confluent melanoma cells cultured in c-RPMI at 37°C, 5% CO 2 . After 48 hours of incubation with NDV, nonadherent cells were discarded; viable adherent cells were washed several times in phosphate-buffered saline (PBS) before further use.
Generation of cloned human TIL lines
Cell suspensions were prepared by mincing freshly resected tumors into small pieces and digesting them in c-RPMI 1640 culture medium (20% human AB sera, 1% penicillin/streptomycin, 1% L-glutamine, and 1% sodium pyruvate (Seromed)) containing 0.1% collagenase type IV (200 U/mg) and 0.005% deoxyribonuclease type I (100 U/mg) (all from Sigma) for 12 hours. The digested cell suspension was passaged through a steel sieve, and viable mononuclear cells were separated on a Ficoll-Hypaque gradient (Pharmacia, Erlangen, Germany) at 600 ϫ g for 20 minutes. Limiting dilution cloning of T cells was performed as described previously. 22 Briefly, 0.5 T cells/well were layered onto 5 ϫ 10 3 autologous ␥-irradiated (50 Gy) melanoma cells and onto 5 ϫ 10 3 ␥-irradiated (50 Gy) cells/ well of the Epstein-Barr virus-transformed B-cell line LAZ 509 as feeder cells in a 96-well, round-bottom microtiter plate (Greiner, Frickenhausen, Germany). Colonies were expanded by addition of c-RPMI 1640 supplemented with 200 U/mL IL-2 (Biozol, Eching, Germany), every 3 days. Cloned CD4 T cells were depleted from contaminating cytotoxic T lymphocytes or B cells by incubation with anti-CD8 mAb (clone UCHT-4) (Dianova) and anti-CD20 mAb (clone L26) (Dako) for 45 minutes in PBS on ice followed by the addition of cytolytic low-tox TM rabbit complement (Cedarlane, Hornby, Ontario, Canada) for 20 minutes at 37°C, 5% CO 2 . Viable cells were separated on a Ficoll-Hypaque gradient, resuspended, and maintained in c-RPMI 1640 supplemented with 30 U/mL IL-2 for 7 days. Cells obtained from this protocol remained nonproliferative to stimulation with phytohemagglutinin (3 g/ mL) and were rested in c-RPMI 1640 without IL-2 for 4 days before being used for any coculture experiments.
Fluorescence-activated cell sorter (FACS) analysis
Cells were harvested, washed in PBS, incubated with the primary mAb for 30 minutes at 4°C, washed twice, and subsequently stained with the appropriate fluorescein isothiocyanate-labeled secondary mAb. To determine cell viability and to exclude nonviable cells, propidium iodide (1 mg/mL) (Sigma) was added. A total of 5 ϫ 10 4 cells were collected using a FACScan TM and analyzed using CellQuest TM research software (both from Becton Dickinson, Heidelberg, Germany).
HLA phenotyping
The standard complement-dependent microlymphocytotoxicity test (Biotest Diagnostic, Munich, Germany) was performed in microtiter trays with incubation times of 30/60 minutes for MHC class I and 60/120 minutes for MHC class II typing, respectively. The HLA phenotype of patient C was A1/11, B8/40, Cw3, DR 5/7, DQw3; the HLA phenotype of patient S was A2/28, Bw53, Cw6, Drw13.
IL-2 enzyme-linked immunosorbent assay (ELISA)
Supernatants from T-cell proliferation assays were collected after 24 hours of incubation and spun for 10 minutes at 4°C, 2500 rpm to obtain cell-free supernatants. ELISAs were developed according to the manufacturer's instructions (Biozol), and the contents of human IL-2 were determined at an extinction of 630 nm using a Dynatech MR 5000 ELISA reader and analyzed using Bio-Linx TM software (both Dynatech, Chantilly, Va). 
T-cell proliferation assay
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were isolated from 1 ϫ 10 7 cloned T cells according to the method of Schreiber et al. 36 Cells were suspended in 400 L of cold buffer A (10 mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid (HEPES) (pH 7.9), 10 mM KCl, 0.1 mM ethylenglycol-bis-(aminoethyl ether)-N,N,NЈ,NЈ-tetraacetic acid, 1 mM dithiothreitol (DTT), and 0.5 mM phenylmethlysulfonyl fluoride (all from Sigma)). The cells were allowed to swell on ice for 15 minutes, after which 25 L of a 10% solution of Nonidet P-40 was added and shaken vigorously. Supernatants were discarded after sedimentation, and the nuclear pellet was resuspended in 80 L of ice-cold buffer C (20 mM HEPES (pH 7.9), 0.4 mM NaCl, 1 M ethylenediaminetetraacetic acid (EDTA), 1 mM ethyleneglycol-bis-(aminoethyl ester)-N,N,NЈ,NЈ-tetraacetic acid, 1 mM DTT, and 1 mM phenylmethylsulfonyl fluoride) and vigorously rocked for 15 minutes; nuclear extracts were cleared by centrifugation. Protein content was assayed using Bradfort reagent (BioRad, Hamburg, Germany). The following double stranded oligonucleotide was used to detect protein binding to the CD28RE: AAAGAAATTCCAAAGAAAAGAAATTC-CAAAGA.
Recognition sequences were end-labeled by coincubation with [␥-32 P]adenosine triphosphate (Amersham) and polynucleotide kinase. Each reaction contained 10 fmol of probe and 5 g of protein of nuclear extracts. Binding reactions were conducted in 50 mM HEPES, 30% glycerol, 50 mM KCl, 10 mM MgCl, 1 mM EDTA, 1 mM DTT, and 1 g poly(dI-dC) in a final volume of 15 L for 20 minutes at 4°C. Complexes were resolved on 6% non-denaturing polyacrylamide gel in 50 mM tris(hydroxymethyl)aminomethane, 45 mM borate, and 0.5 mM EDTA (pH 7.5). Samples were subjected to electrophoresis for 2 hours at 10 V/cm. Gels were dried and autoradiographed at Ϫ70°C overnight.
RESULTS
The autologous melanoma cell line SMS induces anergy in the Th clone sTS3 TILs were isolated from freshly resected primary tumors; cloning of the autologous Th cell clone sTS3 was performed as described in Materials and Methods. FACS analysis revealed expression of CD2, CD3, CD4, CD11a, CD25, and CD28, whereas no staining of CD8, CD14, CD16, CD21, or CD56 was detected ( Table 1 ). The melanoma cell line SMS expressing HLA-DRw13 was established from the same tumor specimen; the allogeneic cell line SMC expressing HLA-DR 5/7 was established from a second donor. Both cell lines showed strong expression of the melanocytic marker HMB-45 as well as of CD54 and lacked expression of the costimulatory molecules B7-1 or B7-2. sTS3 exerted no natural or lymphokine-activated killer cell activity as measured by killing of K562 or Daudi cells and revealed Ͻ5% lysis in an effector to target ratio of 40:1. No cytotoxicity against SMS could be detected in a 4-hour 51 Cr release assay, as specific lysis was Ͻ5% at an effector to target ratio of 40:1.
In melanoma cell/T-cell cocultures, no proliferative response or IL-2 production of sTS3 could be induced after 24 hours of coculture with the autologous melanoma cell line SMS (Fig 1C) . However, coincubation with a stimulating anti-CD28 mAb induced proliferation and IL-2 production in sTS3 in response to SMS ( Fig  1D) ; this proliferation was comparable with the proliferation induced by the combination of a TCR-crosslinking anti-CD3 and anti-CD28 mAb (Fig 1B) . By contrast, coincubation with the allogeneic melanoma cell line SMC failed to induce proliferation (Fig 1, E and F) . These results, in combination with the fact that sTS3 is a CD4 ϩ Th cell clone, suggest a MHC class II-restricted, TCR-mediated interaction between sTS3 and SMS that remained nonproliferative due to a lack of costimulatory activity on SMS. *sTS3 T cells were stained for expression of different lymphocytic markers and analyzed by FACS. The purity of the T lymphocytes was Ͼ95%; viability was Ͼ98%. Data are expressed as mean fluorescence intensities of three independent experiments Ϯ SD.
NDV infection induces a costimulatory activity in SMS melanoma cells
To determine the effect of NDV infection in this system, the melanoma cells were exposed to NDV before coculture with sTS3 T cells. We found that coculturing sTS3 cells with NDV-infected SMS induced a marked proliferation of sTS3 cells along with an enhanced IL-2 production (Fig 2D) . The effects of NDV infection were similar to the results obtained after maximal stimulation with cross-linking anti-CD3/anti-CD28 mAbs (Fig 2B) . To exclude the possibility that NDV infection itself leads to sTS3 activation, we cocultured sTS3 with NDVinfected cells of the allogeneic melanoma cell line SMC. Under these conditions no enhanced proliferation or IL-2-production could be observed (Fig 2, E and F) .
Coincubation with NDV-infected SMS prevents sTS3 from induction of anergy
Because NDV infection induced costimulatory activity on melanoma cells, we questioned whether NDV infection could also prevent the induction of T-cell anergy. Therefore, sTS3 cells were cocultured for 24 hours with NDV-infected or untreated melanoma cells. T cells were separated from melanoma cells on the following day and cultured in C-RPMI supplemented with 30 U/mL IL-2 for 4 days; next, the cells were transferred to a proliferation assay in the presence or absence of cross-linking anti-CD3/anti-CD28 mAbs. Coculture of sTS3 with the autologous tumor SMS resulted in unresponsiveness to subsequent stimulations with anti-CD3/anti-CD28 mAbs (Fig 3D) , whereas coincubation with the allogeneic melanoma cell line SMC did not inhibit subsequent activation via anti-CD3/anti-CD28 mAbs (Fig 3F) . Notably, the induction of unresponsiveness was prevented by pre-coculture with NDV-infected autologous melanoma cells (Fig 3G) .
Costimulatory activity of NDV-infected SMS is not mediated by B7-1 or B7-2
To further assess the enhanced costimulatory activity of NDV-infected melanoma cells, we tested whether this effect was dependent upon an up-regulated expression of B7-1 or B7-2 costimulatory molecules on SMS. FACS analysis of NDV-infected melanoma cells showed that neither B7-1 nor B7-2 were expressed on SMS (Table 2, SMS and SMS-NDV) or on SMC (Table 2 , SMC and SMC-NDV) as levels comparable with the expression levels found on professional APCs (Table 2 , dendritic cells). Nevertheless, because the costimulatory signal was MHC class II-restricted and could also prevent the induction of anergy, we presume that another as yet unidentified costimulatory factor is being expressed on melanoma cells.
CD28-mediated signaling induced in sTS3 by coincubation with NDV-infected SMS
The signaling induced by the costimulatory molecules B7-1/B7-2 has been reported to be mediated via the CD28 receptor on T cells. Furthermore, it has been *SMS were stained with the matched isotype control. †Melanoma cells were NDV-infected or left untreated and stained for B7-1 or B7-2 expression. Data are expressed as mean fluorescence intensities of three independent experiments Ϯ SD.
‡Monocyte-derived human dendritic cells.
shown that stimulation of CD28 induces the formation of a CD28-specific protein complex (CD28-responsive complex) that binds to a distinct site on the IL-2 promoter, leading to enhanced IL-2 promoter activity and IL-2 transcription. To determine whether this highly specific signaling pathway was involved in NDV-mediated T-cell stimulation, EMSAs were performed using the CD28RE as an oligonucleotide probe. Nuclear proteins of sTS3 cells extracted 6 hours after coincubation with cross-linking anti-CD3/anti-CD28 mAbs (Fig 4A) or coincubation with a B7-1 transfectant of SMS showed strong protein binding (Fig 4B) . By contrast, this complex could not be detected in sTS3 cells cocultured with untreated SMS cells (Fig 4C) . Coculture of sTS3 with NDV-infected SMS (Fig 4D) , however, induced a binding activity in sTS3 nuclear extracts that was comparable with that induced by other maximal stimuli (Fig 4, A and  B) . These results imply that the CD28 receptor was engaged by a costimulatory signal mediated by NDVinfected SMS. The specificity of the reaction was demonstrated by the addition of excess unlabeled CD28RE oligonucleotide, which completely abolished protein binding (Fig 4E) .
DISCUSSION
Here we report the prevention of T-cell anergy by NDV infection of melanoma cells in a single autologous MHC class II-restricted tumor model, consisting of the strong MHC class II ϩ , but only faintly B7-1/B7-2-expressing melanoma cell line SMS, which induces anergy in its specific CD4
ϩ Th cell clone sTS3. We confirmed previous observations that melanoma cells are expressing low surface levels of B7-1/B7-2, which are not functional, 29, 30 but induce anergy in TILs. 31, 32 Subsequent to NDV infection, the melanoma cell line SMS became immunogenic, with the ability not only to immediately activate proliferation and IL-2 production of sTS3 cells but also to prevent the induction of clonal anergy. Furthermore, the costimulatory signal induced by NDV infection apparently led to the appearance of a binding activity to the CD28RE in nuclear extracts of the responding T-cell clone sTS3. Interestingly, this effect of NDV was not mediated by the known costimulatory molecules B7-1 or B7-2; nevertheless other yet unidentified costimulatory factors might be involved.
Previous evidence for an enhancement of costimulatory molecules by viral proteins was provided by studies of influenza virus-infected professional APCs. 37 In this system, virus infection of murine splenic APCs was correlated with an up-regulation of B7-2. However, coculture of APCs with CD8
ϩ T cells induced a comparable amount of B7-2 without costimulatory activity, 37 suggesting the expression of a costimulatory molecule different from B7-1 or B7-2 after virus infection. The evidence presented above was further supported by the observation that NDV directly influences the transcription of cellular proteins by the induction of gene activation (for instance the nuclear factor-B-mediated enhancement of nitric oxide synthesis in macrophages). 38 Similar effects were also demonstrated by Lorence and colleagues, 14, 15 who found augmented tumor necrosis factor-␣ (TNF-␣) production of human peripheral blood mononuclear cells (PBMCs) in an allogenic system consisting of PBMCs from healthy donors and two human melanoma cell lines. More interestingly, NDV infection also enhanced the susceptibility of the TNF-␣-resistant melanoma cell line Mel21 to TNF-␣-mediated lysis by up to 55%. Thus finding suggests that in this system, the viral infection primarily targets the tumor cells; the TNF-␣ release of the PBMCs is only a secondary phenomenon in response to the enhanced immunogenicity of the melanoma cells.
Our data imply that this effect of NDV is due to an enhanced expression of costimulatory molecules on melanoma cells. This is in accordance with the finding that NDV infection efficiently prevents the growth and micrometastasis of established B16 melanoma in immunocompetent mice only if these are MHC-matched. 39 Furthermore, lymphocytes play an essential role in NDV-mediated tumor lysis in vivo, because depletion of CD4 ϩ , CD8
ϩ , or natural killer cells in these mice reversed the immunotherapeutic effects of the vaccine. 39 Similar results were obtained by von Hoegen et al, 16, 17 who characterized the effects of NDV infection in a murine model using the highly metastatic murine lymphoma line ESb injected in immunocompetent syngenic DBA/2 mice. They demonstrated that spleen cells from mice immunized with NDV-infected ESb cells contain an enhanced immune capacity in both CD4 ϩ and CD8 ϩ T-cell compartments. 16, 18 CD4 ϩ Th cells were found to produce significantly more IL-2 after stimulation with NDV-infected ESb. There was no participation of either CD4 ϩ or CD8 ϩ virus-specific T cells in the augmented response, 18 ruling out the possibility that viral peptides presented by MHC on the surface of the tumor cells were responsible for the NDV effect. Nevertheless, Plaksin et al 39 indicated that specific immune recognition of a tumor Ag by the TCR of CD4
ϩ Th cells appeared to be a requirement 17 for the immunomodulatory effect of NDV.
Clinical data obtained from patients undergoing postoperative active specific immunization with autologous NDV-modified tumor cells support this hypothesis. 8, 10, 11 In vitro expansion and analysis of T-lymphocyte microcultures obtained from the vaccination sites showed expression of CD4 and TCR-␣␤ in the majority of infiltrating lymphocytes. 8 Thus, immunization with NDV-infected autologous tumor cells seems to be capable of augmenting specific T-cell-mediated antitumoral immune responses, thereby generating systemic protection against micrometastases or minimal residual disease.
In conclusion, active immunotherapy of melanoma patients based on NDV-infected cellular vaccines may provide a useful reagent in helping to control the tumor cell seeding and spreading after surgical removal of the primary tumor, with the major advantage of few side effects. Here, we investigated the effects of NDV infection on an autologous human in vitro tumor model. We have found evidence that the enhanced costimulatory activity induced by NDV infection on melanoma cells is mediated by a CD28-dependent signal but is independent of up-regulation of the costimulatory molecules B7-1/B7-2.
